Liver CPT1A gene therapy reduces diet‐induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD-Reference-Cited by-同舟云学术

Liver CPT1A gene therapy reduces diet‐induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD

Published:2020-07-15 Issue:9 Volume:34 Page:11816-11837
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Weber Minéia¹,Mera Paula¹²,Casas Josefina³⁴,Salvador Javier²⁵,Rodríguez Amaia²⁶,Alonso Sergio⁷,Sebastián David⁸⁹,Soler‐Vázquez M. Carmen¹,Montironi Carla¹⁰¹¹,Recalde Sandra¹,Fucho Raquel¹,Calderón‐Domínguez María¹,Mir Joan Francesc¹,Bartrons Ramon¹²,Escola‐Gil Joan Carles⁹¹³,Sánchez‐Infantes David²¹⁴,Zorzano Antonio⁸⁹,Llorente‐Cortes Vicenta¹⁵¹⁶¹⁷,Casals Núria²¹⁸,Valentí Víctor⁶¹⁹,Frühbeck Gema²⁶,Herrero Laura¹²,Serra Dolors¹²

Affiliation:

1. Department of Biochemistry and Physiology School of Pharmacy and Food Sciences Institut de Biomedicina de la Universitat de Barcelona (IBUB)Universitat de Barcelona Barcelona Spain

2. Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Instituto de Salud Carlos III Madrid Spain

3. Research Unit on BioActive Molecules Department of Biological Chemistry Institute of Advanced Chemistry of Catalonia (IQAC)/CSIC Barcelona Spain

4. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Instituto de Salud Carlos III Madrid Spain

5. Department of Endocrinology & Nutrition Clínica Universidad de Navarra Pamplona Spain

6. Metabolic Research Laboratory Clínica Universidad de NavarraIdiSNA Pamplona Spain

7. Cancer Genetics and Epigenetics Group, Program of Predictive and Personalized Medicine of Cancer Germans Trias i Pujol Research Institute (IGTP‐PMPPC)Campus Can Ruti Barcelona Spain

8. Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia Universitat de Barcelona Barcelona Spain

9. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Instituto de Salud Carlos III Madrid Spain

10. Pathology Department Hospital Clinic de Barcelona Barcelona Spain

11. Liver Cancer Translational Research Laboratory, Liver Unit IDIBAPS‐Hospital ClínicUniversitat de Barcelona Barcelona Spain

12. Departament de Ciències Fisiològiques Facultat de Medicina i Ciències de la SalutUniversitat de Barcelona Spain

13. IIB Sant Pau Departament de Bioquímica i Biologia Molecular Universitat Autònoma de Barcelona Barcelona Spain

14. Germans Trias i Pujol Research Institute (IGTP‐PMPPC)Campus Can Ruti Barcelona Spain

15. Institute of Biomedical Research of Barcelona (IIBB) Spanish National Research Council (CSIC)Biomedical Research Institute Sant Pau (IIB Sant Pau) Barcelona Spain

16. CIBERCVInstitute of Health Carlos III Madrid Spain

17. Cardiovascular Research CenterCSIC‐ICCC Barcelona Spain

18. Basic Sciences Department Faculty of Medicine and Health Sciences Universitat Internacional de Catalunya Sant Cugat del Vallès Spain

19. Department of Surgery Clínica Universidad de Navarra Pamplona Spain

Funder

Ministerio de Economía y Competitividad

European Regional Development Fund

Generalitat de Catalunya

Instituto de Salud Carlos III

Fundació la Marató de TV3

European Foundation for the Study of Diabetes

Eli Lilly and Company